DastaJF. Critical care therapeutics: A frontier for clinical pharmacy. Drug Intell Clin Pharm1982; 16: 398–99.
2.
MajerusTC. The critically ill or injured patient: Priorities in management. Drug Intell Clin Pharm1982; 16: 459–63.
3.
MajerusTCDastaJF eds. Practice of critical care pharmacy. Rockville, MD: Aspen Systems, 1985.
4.
DastaJFAngaranDM. Evolving role of the pharmacist in critical care. Crit Care Med (in press).
5.
LobasNHArmitsteadJAIveyMF. Expanding staff pharmacists' responsibilities to maintain pharmacy services in a neonatal intensive-care wax. Am J Hosp Pharm1991; 48: 1708–11.
6.
ZenkKE. The pharmacist—a member of the neonatal interdisciplinary team. J Calif Perinatal Assoc1983; 1: 54–9.
7.
DastaJFJacobiJJArmstrongDK. The role of the pharmacist in the care of the critically ill patient. In: ChernowB ed. The pharmacologic approach to the critically ill patient. 3rd ed. (in press).
8.
DastaJF. Drug use in a surgical intensive care unit. Drug Intell Clin Pharm1986; 20: 752–6.
9.
DastaJFArmstrongDK. Pharmacoeconomic impact of critically ill surgical patients. Drug Intell Clin Pharm1988; 22: 994–8.
10.
BoucherBAKuhlDACoffeyBCFabianTC. Drug use in a trauma intensive-care unit. Am J Hosp Pharm1990; 47: 805–10.
11.
GundlachCAFaulknerTPSouneyPF. Drug usage patterns in the ICU: Profile of a major metropolitan hospital and comparison with other ICUs. Hosp Formul1991; 26: 132–6.
12.
LesarTSBricelandLLDelcoureKParmaleeJCMasta-GornicVPohlH. Medication prescribing errors in a teaching hospital. JAMA1990; 263: 2329–34.
DastaJFJacobiJJ. Pharmacist involvement in the Society of Critical Care Medicine (letter). DICP Ann Pharmacother1991; 25: 1398–9.
15.
ASHP supplemental standard and learning objectives for residency training in critical-care pharmacy practice. Am J Hosp Pharm1990; 47: 609–12.
16.
DastaJFSegalRCunninghamA. National survey of critical-care pharmaceutical services. Am J Hosp Pharm1989; 46: 2308–12.
17.
RippeJMIrwinRSAlpertJSFinkMP eds. Intensive care medicine. Boston: Little, Brown and Co., 1991.
18.
ChernowB ed. The pharmacologic approach to the critically ill patient. Baltimore: Williams and Wilkins, 1988.
19.
OrnatoJRGonzalezER. Drug treatment in emergency medicine. New York: Churchill Livingstone, 1990.
20.
BlummerJBondGR eds. Toxic effects of drugs used in the ICU. Med Clin North Am1991; 7: 489–762.
21.
ReynoldsHNHauptMTThil-BaharozianMCCarlsonRW. Impact of critical care physician staffing on patients with septic shock in a university hospital medical intensive care unit. JAMA1988; 260: 3446–50.
22.
HatoumHTCatizoneCHutchinsonRAPurohitA. An eleven-year review of the pharmacy literature: Documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm1986; 20: 33–48.
23.
WillettMSBertchKERichDSEreshefskyL. Prospectus on the economic value of clinical pharmacy services—a position statement of the American College of Clinical Pharmacy. Pharmacotherapy1989; 9: 45–56.
24.
StumpfJLLechnerJLRyanML. Use of albumin in a university hospital: The value of targeted physician intervention. DICP Ann Pharmacother1991; 25: 239–43.
25.
LudwigDJAbramowitzPW. The pharmacist as a member of the CPR team: Evaluation by other health professionals. Drug Intell Clin Pharm1983; 17: 463–5.
26.
KasuyaABaumanJLCurtisRADuarteBHutchinsonRA. Clinical pharmacy on-call program in the emergency department. Am J Emerg Med1986; 4: 464–7.
27.
MiyagawaCIRiveraJO. Effect of pharmacist interventions on drug therapy costs in a surgical intensive-care unit. Am J Hosp Pharm1986; 43: 3008–13.
28.
BearceWCWileyGAFoxRLColemanLT. Documentation of clinical interactions: Quality of care issues and economic considerations in critical care pharmacy. Hosp Pharm1988; 23: 883–90.
29.
KatonaBGAydPRWaltersJKCaspiMFinkelsteinBW. Effect of a pharmacist's and nurse's interventions on cost of drug therapy in a medical intensive-care unit. Am J Hosp Pharm1989; 46: 1179–82.
30.
RosenbaumCLFantWKMiyagawaCIArmitsteadJA. Inability to justify a part-time clinical pharmacist in a community hospital intensive-care unit. Am J Hosp Pharm1991; 48: 2154–7.
31.
HadbavnyAMPoirierTI. The role of a clinical pharmacist in implementing cost-effective benzodiazepine sedation for critically ill patients (abstract). Pharmacotherapy1991; 11: P–33.
32.
BroylesJEBrownROVeheKLNollyRJLutherRW. Pharmacist interventions improve fluid balance in fluid-restricted patients requiring parenteral nutrition. DICP Ann Pharmacother1991; 25: 119–22.
33.
GreenbaumDM. Availability of critical care personnel, facilities, and services in the United States. Crit Care Med1984; 12: 1073–7.
34.
Task Force on Guidelines.Recommendations for services and personnel for delivery of care in a critical care setting. Crit Care Med1988; 16: 809–11.
35.
CrispCBLaneJRMurrayW. Audit of serum drug concentration analysis for patients in the surgical intensive care unit. Crit Care Med1990; 18: 734–7.
36.
FerrisNH. Justification of a critical care satellite pharmacy. Calif J Hosp Pharm1990; 2: 35–7.
37.
DastaJF. Assessment of critical care pharmacy practice. Calif J Hosp Pharm1990; 2: 30–2.